These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37128191)

  • 61. Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson's Disease.
    Massaquoi MS; Liguore WA; Churchill MJ; Moore C; Melrose HL; Meshul CK
    Neuroscience; 2020 May; 433():53-71. PubMed ID: 32142862
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice.
    Shan X; Chi L; Bishop M; Luo C; Lien L; Zhang Z; Liu R
    Stem Cells; 2006 May; 24(5):1280-7. PubMed ID: 16424396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson's disease.
    Zuo T; Xie M; Yan M; Zhang Z; Tian T; Zhu Y; Wang L; Sun Y
    Cell Prolif; 2022 Apr; 55(4):e13213. PubMed ID: 35274781
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.
    Fricke IB; Viel T; Worlitzer MM; Collmann FM; Vrachimis A; Faust A; Wachsmuth L; Faber C; Dollé F; Kuhlmann MT; Schäfers K; Hermann S; Schwamborn JC; Jacobs AH
    Eur J Neurosci; 2016 May; 43(10):1352-65. PubMed ID: 26950181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selegiline rescues gait deficits and the loss of dopaminergic neurons in a subacute MPTP mouse model of Parkinson's disease.
    Zhao Q; Cai D; Bai Y
    Int J Mol Med; 2013 Oct; 32(4):883-91. PubMed ID: 23877198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Notch1 signaling modulates neuronal progenitor activity in the subventricular zone in response to aging and focal ischemia.
    Sun F; Mao X; Xie L; Ding M; Shao B; Jin K
    Aging Cell; 2013 Dec; 12(6):978-87. PubMed ID: 23834718
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice.
    Yamada M; Onodera M; Mizuno Y; Mochizuki H
    Neuroscience; 2004; 124(1):173-81. PubMed ID: 14960349
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice.
    Kong XY; Cai Z; Pan L; Zhang L; Shu J; Dong YL; Yang N; Li Q; Huang XJ; Zuo PP
    Brain Res; 2008 Apr; 1205():108-15. PubMed ID: 18353283
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
    Hung HC; Lee EH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
    Li C; Biswas S; Li X; Dutta AK; Le W
    J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
    Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Peng J; Andersen JK
    Aging Cell; 2011 Apr; 10(2):255-62. PubMed ID: 21108729
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice.
    Yang P; Arnold SA; Habas A; Hetman M; Hagg T
    J Neurosci; 2008 Feb; 28(9):2231-41. PubMed ID: 18305256
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.
    Visanji NP; Orsi A; Johnston TH; Howson PA; Dixon K; Callizot N; Brotchie JM; Rees DD
    FASEB J; 2008 Jul; 22(7):2488-97. PubMed ID: 18364399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice.
    Lee J; Duan W; Mattson MP
    J Neurochem; 2002 Sep; 82(6):1367-75. PubMed ID: 12354284
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Brain-Derived Neurotrophic Factor (BDNF) Role in Cannabinoid-Mediated Neurogenesis.
    Ferreira FF; Ribeiro FF; Rodrigues RS; Sebastião AM; Xapelli S
    Front Cell Neurosci; 2018; 12():441. PubMed ID: 30546297
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
    Marchetti B
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.